BioCentury
ARTICLE | Company News

Furiex Pharmaceuticals, Menarini deal

April 8, 2013 7:00 AM UTC

Furiex will receive a $5 million milestone payment from Menarini under a May 2012 deal granting Menarini exclusive rights to commercialize Priligy dapoxetine in Europe, Africa, Latin America, the Mi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article